Search research articles
Contact Us
Filters
Showing results (1031-1040 of 1,095) with videos related to
Page
of 110
Sort By:
European Urology
|
August 15, 2024
First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study
Talal El Zarif, Karl Semaan, Wanling Xie, et al.
Immunotherapy
|
October 18, 2018
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study
Melissa Bersanelli, Diana Giannarelli, Paola Castrignanò, et al.
Iscience
|
October 20, 2023
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis
Shobana Anpalakhan, Alessio Signori, Alessio Cortellini, et al.
Journal of Clinical Microbiology
|
November 8, 2014
High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods
Josep Quer, Josep Gregori, Francisco Rodríguez-Frias, et al.
Journal for Immunotherapy of Cancer
|
October 20, 2020
Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation
Alessio Cortellini, Biagio Ricciuti, Marcello Tiseo, et al.
Gastroenterologia Y Hepatologia
|
June 22, 2024
Characterizing Hepatitis Delta in Spain and the gaps in its management
Sergio Rodríguez-Tajes, Adriana Palom, Álvaro Giráldez-Gallego, et al.
The New England Journal of Medicine
|
May 28, 2026
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection
Jinlin Hou, Seng-Gee Lim, Maria Buti, et al.
Cancer Immunology, Immunotherapy : CII
|
August 31, 2021
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation
Marco Russano, Alessio Cortellini, Raffaele Giusti, et al.
The Kaohsiung Journal of Medical Sciences
|
October 27, 2023
Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs
Tyng-Yuan Jang, Po-Cheng Liang, Dae Won Jun, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2020
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index
Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone, et al.
Page
of 110
Search research articles
Search
Showing results (1031-1040 of 1,095) with videos related to
Sort By:
Page
of 110
European Urology
|
August 15, 2024
First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study
Talal El Zarif, Karl Semaan, Wanling Xie, et al.
Immunotherapy
|
October 18, 2018
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study
Melissa Bersanelli, Diana Giannarelli, Paola Castrignanò, et al.
Iscience
|
October 20, 2023
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis
Shobana Anpalakhan, Alessio Signori, Alessio Cortellini, et al.
Journal of Clinical Microbiology
|
November 8, 2014
High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods
Josep Quer, Josep Gregori, Francisco Rodríguez-Frias, et al.
Journal for Immunotherapy of Cancer
|
October 20, 2020
Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation
Alessio Cortellini, Biagio Ricciuti, Marcello Tiseo, et al.
Gastroenterologia Y Hepatologia
|
June 22, 2024
Characterizing Hepatitis Delta in Spain and the gaps in its management
Sergio Rodríguez-Tajes, Adriana Palom, Álvaro Giráldez-Gallego, et al.
The New England Journal of Medicine
|
May 28, 2026
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection
Jinlin Hou, Seng-Gee Lim, Maria Buti, et al.
Cancer Immunology, Immunotherapy : CII
|
August 31, 2021
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation
Marco Russano, Alessio Cortellini, Raffaele Giusti, et al.
The Kaohsiung Journal of Medical Sciences
|
October 27, 2023
Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs
Tyng-Yuan Jang, Po-Cheng Liang, Dae Won Jun, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2020
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index
Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone, et al.
Page
of 110